Lewis Asset Management »

Intellia Therapeutics shares owned by Lewis Asset Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Lewis Asset Management from 13F filings

Historical chart of Lewis Asset Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Lewis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Lewis Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $842k 31k 27.51
2023-12-31 $704k 23k 30.49

More positions owned by Lewis Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr Ser Tr S&p Divid Etf (SDY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Rithm Capital Corp Com New (RITM)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl C (GOOG)
Angel Oak Funds Trust Oak Ultrashort (UYLD)
Crowdstrike Hldgs Cl A (CRWD)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
salesforce (CRM)
Atlassian Corporation Cl A (TEAM)

View all positions for Lewis Asset Management

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Wellington Management Company
Federated Investors
T. Rowe Price Associates
Alliancebernstein
Citadel Advisors
Rokos Capital Management
Casdin Capital
Dimensional Fund Advisors
Chevy Chase Trust Holdings
Marshall Wace
Goldman Sachs Group

View all funds holding Intellia Therapeutics